Composition, form of production and packaging
Capsules hard gelatinous, the case and a cover of white color; the content of capsules is an amorphous powder of white-gray or white-yellow color, with a specific odor.
lyophilized dried spores of Bacillus cereus IP 5832 35 mg
Excipients: calcium carbonate - 25 mg, kaolin - 100 mg.
The composition of the capsule shell: titanium dioxide (E171), gelatin.
20 pcs. - blisters (1) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
Description of the drug approved by the manufacturer for the printed edition of 2014.
Eubiotic. Bacillus cereus IP 5832 bacteria release broad spectrum antibacterial agents that inhibit the development of pathogenic and conditionally pathogenic bacteria, which have an antimicrobial, antidiarrheal effect, restores the intestinal microflora. Spores of bacteria contained in the preparation are resistant to the action of gastric juice. Their germination in vegetative forms of bacteria occurs in the intestine.
Data on the pharmacokinetics of Bactisubtil В® are not available.
- Treatment of acute and chronic diarrhea of вЂ‹вЂ‹various genesis;
- treatment of colitis, enterocolitis;
- prevention and treatment of intestinal dysbacteriosis (including those that developed as a result of antibiotic or chemo- or radiotherapy).
Bactisubtil В® is prescribed for children over 7 years and adults.
Children older than 7 years are prescribed 1-2 capsules 2-3 times / day for 7-10 days.
Adults and adults are prescribed 2 capsules 2-4 times / day for 7-10 days.
Bactisubtil В® should be taken 1 hour before meals.
Do not drink Bactisubthil В® with a hot liquid or take it with alcoholic beverages.
When applying the drug in accordance with the recommended dosing regimen, side effects are not established.
- primary immunodeficiencies;
- Hypersensitivity to the components of the drug.
PREGNANCY AND LACTATION
Data on the safety of Bactisubtil В® during pregnancy are not provided.
APPLICATION FOR CHILDREN
The drug is prescribed for children older than 7 years.
The drug is used as directed by a doctor. Patients should not take the drug uncontrollably or on the advice of third parties.
If the treatment does not improve within 3 days, the drug should be discontinued.
The patient should inform the attending physician about parallel medications.
TERMS OF RELEASE FROM PHARMACY
It is released by prescription.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored out of reach of children, dry, protected from light at a temperature below 25 В° C. Shelf life - 3 years.
Transportation: at a temperature below 25 В° C.